...
首页> 外文期刊>Tropical Medicine and Health >In vitro effect of current antimalarial drugs on the survival of paired Schistosoma mansoni adult worms and their egg production.
【24h】

In vitro effect of current antimalarial drugs on the survival of paired Schistosoma mansoni adult worms and their egg production.

机译:当前抗疟药对成对曼氏血吸虫成虫的存活及其产卵的体外作用。

获取原文
           

摘要

Some field trials have already demonstrated the high antischistosomal potential of combination therapies using Artesunate (ART) and current antimalarial drugs (Boulanger et al., 2007; Mohamed et al., 2009; Sissoko et al., 2009). The antischistosomal effects of these drugs are noteworthy, especially when they are used for the treatment of malaria in schistosomiasis endemic areas. However, the antischistosomal effects of Amodiaquine (AQ), Primaquine (PQ), Chloroquine (CQ) and Pyrimethamine (Py) have never been assessed by in vitro incubation. The objective of the present study is to assess the in vitro effects of current antimalarial drugs on the egg productivity of adult worm pairs of S. mansoni and their survival times. The effect of the current antimalarial drugs Mefloquine (MQ), quinine (QN), AQ, PQ, CQ, Sulfadiazine (Sf) and Py on the egg output of adult worm pairs of Schistosoma mansoni and their survival times during in vitro culture were assessed at a concentration of 10 Μg?ml. AQ, PQ, CQ and Py significantly inhibited the daily egg output of paired female worms at a concentration of 10 Μg?ml during the 1 or 2-day in vitro cultivation. However, QN and Sf did not significantly affect the daily egg output during the 8-day incubation. One-day exposure to MQ killed all paired male and female adult worms. AQ and PQ significantly decreased the survival of both paired male and female worms during the 14-day incubation, but QN, CQ, Py and Sf did not exert any similar effect. The present result is consistent with an assessment of the antischistosomal effects of artemisinin-based combination therapy in malaria and schistosomiasis co-endemic areas.
机译:一些现场试验已经证明,使用青蒿琥酯(ART)和目前的抗疟药联合治疗具有很高的抗血吸虫病潜力(Boulanger等,2007; Mohamed等,2009; Sissoko等,2009)。这些药物的抗血吸虫病作用是值得注意的,尤其是当它们用于在血吸虫病流行地区治疗疟疾时。但是,从未通过体外温育评估过阿莫地喹(AQ),伯氨喹(PQ),氯喹(CQ)和乙胺嘧啶(Py)的抗血吸虫病作用。本研究的目的是评估目前的抗疟疾药物对曼氏沙门氏菌成虫对卵生产力及其存活时间的体外影响。评估了目前的抗疟药甲氟喹(MQ),奎宁(QN),AQ,PQ,CQ,磺胺嘧啶(Sf)和Py对曼氏血吸虫成虫蠕虫卵产量及其在体外培养期间的存活时间的影响浓度为10毫克/毫升。在体外培养1天或2天期间,AQ,PQ,CQ和Py在浓度为10 Mg?ml的情况下显着抑制成对雌性蠕虫的每日卵产量。但是,QN和Sf在8天的孵化过程中并未显着影响每日的卵产量。每天暴露于MQ会杀死所有成对的成年男性和女性成虫。在14天的温育过程中,AQ和PQ显着降低了成对的雄虫和雌虫的存活率,但是QN,CQ,Py和Sf没有发挥任何类似的作用。本结果与对基于青蒿素的联合治疗在疟疾和血吸虫病流行地区的抗血吸虫病作用的评估相一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号